In this issue... updates on our 2024 share tips, the latest on our Aggressive Portfolio IX, plus company features and market insight.
Try this medicine for growth!
As regular readers will know, we rarely feature stocks in the FTSE 100 Index in the newsletter as we feel that we should be focusing on smaller companies which we think are overlooked and undervalued. However, there are occasions when large company stocks also appear to offer good value and we believe that we have identified one of these in AstraZeneca (9600p) following the recent fall in the share price of the company.
As readers will be aware, the company is one of the largest constituents of the FTSE 100 Share Index…
CONTINUED IN THE FULL NEWSLETTER CLICK TO READ
